Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Leeper

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
Circulation|January 12, 2011
MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitusNicholas J Leeper, John P Cooke
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of Modulating MicroRNA in Peripheral Artery DiseaseNaomi M Hamburg, Nicholas J Leeper
Nature Cardiovascular Research|August 28, 2024
Killing the two deadly birds of atherosclerosis and cancer with one stoneCaitlin F Bell, Nicholas J Leeper
Nature Reviews. Cardiology|May 15, 2024
Efferocytosis in atherosclerosisShaunak S Adkar, Nicholas J Leeper
The New England Journal of Medicine|September 27, 2023
An Alternate Explanation. ReplyTom Alsaigh, Nicholas J Leeper, Nazish Sayed
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2019
Clonal Smooth Muscle Cell Expansion, Autophagy, and Vascular Integrity in Aortic Aneurysm DiseaseYing Wang, Vivek Nanda, Nicholas J Leeper
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2024
Peripheral Artery Disease: Molecular Mechanisms and Novel TherapiesAnand Athavale, Eri Fukaya, Nicholas J Leeper
Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2014
MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contributionLars Maegdefessel, Katey J Rayner, Nicholas J Leeper
Circulation|February 1, 2017
The Role of Efferocytosis in AtherosclerosisYoko Kojima, Irving L Weissman, Nicholas J Leeper
European Heart Journal|September 9, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibitionKai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
Circulation|January 12, 2011
MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitusNicholas J Leeper, John P Cooke
Current Vascular Pharmacology|May 30, 2013
Therapeutic Potential of Modulating MicroRNA in Peripheral Artery DiseaseNaomi M Hamburg, Nicholas J Leeper
Nature Cardiovascular Research|August 28, 2024
Killing the two deadly birds of atherosclerosis and cancer with one stoneCaitlin F Bell, Nicholas J Leeper
Nature Reviews. Cardiology|May 15, 2024
Efferocytosis in atherosclerosisShaunak S Adkar, Nicholas J Leeper
The New England Journal of Medicine|September 27, 2023
An Alternate Explanation. ReplyTom Alsaigh, Nicholas J Leeper, Nazish Sayed
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2019
Clonal Smooth Muscle Cell Expansion, Autophagy, and Vascular Integrity in Aortic Aneurysm DiseaseYing Wang, Vivek Nanda, Nicholas J Leeper
Arteriosclerosis, Thrombosis, and Vascular Biology|May 22, 2024
Peripheral Artery Disease: Molecular Mechanisms and Novel TherapiesAnand Athavale, Eri Fukaya, Nicholas J Leeper
Arteriosclerosis, Thrombosis, and Vascular Biology|December 19, 2014
MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contributionLars Maegdefessel, Katey J Rayner, Nicholas J Leeper
Circulation|February 1, 2017
The Role of Efferocytosis in AtherosclerosisYoko Kojima, Irving L Weissman, Nicholas J Leeper
European Heart Journal|September 9, 2025
The atherosclerosis-cancer axis: the shared immunotherapeutic potential of CBL inhibitionKai-Uwe Jarr, Lingfeng Luo, Nicholas J Leeper
Pageof 18